acetylcysteine 600mg capsules
tor generics ltd - acetylcysteine - oral capsule - 600mg
acetylcysteine 600mg capsules
a a h pharmaceuticals ltd - acetylcysteine - oral capsule - 600mg
acetylcysteine 600mg capsules
alissa healthcare research ltd - acetylcysteine - oral capsule - 600mg
acetylcysteine 600mg tablets
alissa healthcare research ltd - acetylcysteine - oral tablet - 600mg
acetylcysteine 600mg capsules
de pharmaceuticals - acetylcysteine - oral capsule - 600mg
acetylcysteine 600mg tablets
de pharmaceuticals - acetylcysteine - oral tablet - 600mg
acetylcysteine 600mg capsules
special order - acetylcysteine - oral capsule - 600mg
acetylcysteine 600mg capsules
alliance healthcare (distribution) ltd - acetylcysteine - oral capsule - 600mg
acetylcysteine injection, solution
sagent pharmaceuticals - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion (rsi). acetylcysteine is contraindicated in patients with a previous hypersensitivity reaction to acetylcysteine [see warnings and precautions (5.1)] . risk summary limited published case reports and case series of pregnant women exposed to acetylcysteine during various trimesters are not sufficient to inform any drug associated risk. delaying treatment of acetaminophen overdose may increase the risk of maternal or fetal morbidity and mortality [see clinical considerations]. reproduction studies in rats and rabbits following oral administration of acetylcysteine during the period of organogenesis at doses similar to the total intravenous dose (based on the body surface area) did not cause any adverse effects to the fetus. the estimated background risk of major birth defects and miscarriage
acetylcysteine 600mg capsules
ennogen healthcare ltd - acetylcysteine - oral capsule - 600mg